As a child in Arecibo, Puerto Rico, Dr. Eneida Nemecek learned the effort it takes to earn an education by literally going to college with her parents as they sought their degrees. “My parents are very young. I kind of went to college with both of them in the back of the classroom,” Nemecek said. “My dad ended up going to graduate school, also when I was still a little kid. We went to law school with him, too.” Nemecek followed her parents’ footsteps and eventually got her doctoral degree. Today she’s helping improve Latino health through clinical trial participation as associate director for clinical research at the Oregon Health & Science University (OHSU) Knight Cancer Institute and professor of pediatrics and medical oncology at OHSU.
Developing a Passion for ...
Our collaborative bilingual video that focuses on Latino participation in clinical trials was a "Silver Winner" at both the 2024 W³ Awards and the 45th Annual Telly Awards! The video, created by Genentech with help from the Institute for Health Promotion Research at UT Health San Antonio, the team behind Salud America!, shows why Latino participation in clinical trials is important for the future of clinical research. Clinical trials are studies with volunteers that can help researchers learn how to slow, manage, and treat different cancer and disease. “The lack of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer,” said Dr. Amelie Ramirez, director of Salud America! and the Institute ...
Latinos and other group that experience health differences are frequently left out in spine pain clinical trials, according to an analysis from eight randomized controlled trials (RCTs). The study, published by National Institute of Health and funded by the National Center for Complimentary and Integrative Health, found a lack of participation among vulnerable populations and other overlooked groups. Let’s look further into the data and how it impacts Latinos.
Participation in Clinical Trials on Spinal Pain
The analysis points out that, while RCTs are considered the gold standard study design for evaluating treatment effectiveness, they can suffer from generalizability issues. In other words, the findings of these studies can’t be generalized to the U.S. population because ...
The last thing a person wants to hear from their doctor is “You have cancer.” Unfortunately, that’s the reality for the thousands of Americans, including many Latinos, diagnosed with cancer each year. After a diagnosis, people dealing with cancer discuss treatment options with their medical care team, which may include participation in clinical trials. Clinical trials are studies with volunteers that test ways to find, prevent, and treat cancer and other diseases. They may also help improve the quality of life for volunteers affected by cancer or reduce the side effects of treatment. Despite the benefits of participating in clinical trials, only about one out of every five (21.9%) people with cancer enroll in clinical research, according to a new study in the ...
Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for cancer and other diseases. Still, clinical trials have lacked volunteers who are Latino. We need a variety of participants in clinical trials to ensure health and medical discoveries are fair for all populations. To promote clinical trials, let’s use #SaludTues on Tuesday, Dec. 5, 2023, to discuss reasons why Latinos and all people should consider joining a clinical trial! WHAT: #SaludTues Tweetchat: Why Should You Try a Clinical Trial?
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Dec. 5, 2023
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: LatinaStrong Foundation (@LatinaStrongDr); Public Health Maps ...
Most people with COVID-19 get better within a few days to a few weeks after COVID-19 infection. But some people, including many Latinos, develop long COVID. Long COVID remains an unresolved threat to the health of Latinos and all people. While health experts don’t yet fully understand long COVID symptoms and risk factors, progress is being made regarding treatment. Let’s learn more about how researchers are working to find the most effective therapies for long COVID through research studies and clinical trials.
Relieving the Burden of Long COVID Symptoms
The National Institutes of Health (NIH) launched the RECOVER research study in 2021 to learn why some people experience long COVID or develop new or returning symptoms after COVID-19 infection. Now, based on ...
Despite the ever-growing population of Latinos in the United States, only a very small percentage participate in clinical trials. Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. “[Fewer] Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer, Alzheimer’s, and other diseases,” said Dr. Amelie Ramirez, director of the Salud America! program at UT Health San Antonio. Do you know what happens in a clinical trial? How can clinical trial help you and your friends, family, and community? Why is Latino participation in clinical trials important? Get answers and helpful resources in new bilingual videos from ...
Some Latinos fear becoming a guinea pig. Others worry about cost or trust. But clinical trials can provide volunteers potentially life-saving treatments and help researchers learn how to manage and treat different diseases for their family and communities. UT Health San Antonio held a Zoom webinar — “Busting the Myths and Challenges to Clinical Trials” — at 11 a.m. CT on March 9, 2023. This webinar features health experts and real Latino clinical trial volunteers to help define clinical trials, bust several common myths about clinical trials and share testimonials of trial participation. Panelists will also connect audience members with culturally relevant resources and available opportunities to participate in clinical trials at the Mays Cancer Center at UT Health San ...
Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are four phases of clinical trials that each help scientists answer different questions. Phase 1 clinical trials are the first step in testing a new treatment in people. They focus on evaluating the safety, side effects, best dose, and timing of a new treatment, according to the National Cancer Institute (NCI). Phase 1 clinical trials usually include a small number of patients who have not been helped by other treatments. In the past, participants in phase 1 trials for cancer treatment generally had low tumor response rates. And, because phase 1 trials are focused on assessing safety of treatments, doctors have hesitated to refer patients to these ...
